Adaptive Biotechnologies Corporation Common Stock (NASDAQ: ADPT) last traded at $25.99, up 2.16% on the session. The quote above updates while this page is open; the figures below are drawn from Adaptive Biotechnologies Corporation Common Stock’s own filings and are restated only when a new one is published.
Adaptive Biotechnologies Corporation Common Stock trades on NASDAQ under the ticker ADPT. Its market capitalisation is $4.15 billion.
Valuation measures for Adaptive Biotechnologies Corporation Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $4.15B |
|---|---|
| Enterprise value | $4.47B |
| Price / sales | 13.46 |
| Price / book | 29.02 |
| Beta | 1.85 |
Trailing-twelve-month figures tagged in Adaptive Biotechnologies Corporation Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $308.08M |
|---|---|
| Net income (TTM) | -$63.85M |
| EPS (TTM) | -$0.400 |
| Operating margin | -12.16% |
| Return on equity | -44.68% |
| Cash | $169.87M |
Range and volume for ADPT over the past 52 weeks.
| 52-week high | $26.16 |
|---|---|
| 52-week low | $12.00 |
| Volume | 1.82M |
| Average volume | 2.96M |
| Previous close | $25.44 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.